AutoICD API

82377-3

Laboratory

Ledipasvir [Susceptibility] by Genotype method

Definition

This assay amplifies hepatitis C virus genotypes 1a and 1b to detect the presence of treatment-emergent HCV NS5a variants associated with NS5a inhibitor antiviral therapy.

LOINC 6-Axis Classification

Component

Ledipasvir

Property

Susc

Time Aspect

Pt

System

Isolate

Scale Type

Ord

Method Type

Genotyping

Details

Class

ABXBACT

Order/Observation

Observation

Short Name

Ledipasvir Islt Genotyp

Display Name

Ledipasvir Genotyping [Susc]

Related Names

ANTIBIOTIC SUSCEPTIBILITIESASTGenotypeGenotypicIDInfectious DiseaseInfectiousDiseaseIsltIsolOrdinalPoint in timeQLQualQualitativeRandomScreenSusSusceptSusceptibilitiesSusceptibilitySusceptibilty

Frequently Asked Questions

What is LOINC code 82377-3?

LOINC code 82377-3 identifies "Ledipasvir [Susceptibility] by Genotype method". This assay amplifies hepatitis C virus genotypes 1a and 1b to detect the presence of treatment-emergent HCV NS5a variants associated with NS5a inhibitor antiviral therapy.

What does 82377-3 measure?

This code measures Ledipasvir in Isolate. It belongs to the ABXBACT class in the LOINC classification.

What is LOINC?

LOINC (Logical Observation Identifiers Names and Codes) is a universal standard for identifying laboratory and clinical observations. It is maintained by the Regenstrief Institute and used worldwide for health data exchange.